2030: A future where breast cancer is no longer a deadly disease?

There is a clear need for breaking new ground and keeping up with the pace of innovation to find better treatments for people living with cancer – to give them more time with their loved ones.

Our understanding of breast cancer has evolved exponentially, and we now know that each person living with cancer is unique and requires a personalised treatment approach. Each person’s story is different, and their cancer care journey is often complex and challenging. Novel advances in immunotherapy, targeted therapies, genetic testing, and other innovative technologies have expanded our ability to address unmet needs by identifying specific subtypes of breast cancer.

By targeting a broader range of breast cancer subtypes, we can help more and more people with an aim to extend survival and improve their quality of life as much as possible.

In addition to delivering individualised treatment options to patients, we know that identifying and treating breast cancer earlier in its disease life cycle is critical to increasing the chances of improved management and survival outcomes. By leveraging novel technology, such as precision medicine techniques, we should aim to provide the best care for patients during their whole treatment journey and, continue to invest in early detection and screening.

It's with this understanding that we should come together as a community of healthcare professionals, oncologists, governing bodies and many more, to combine our expertise to bring much-needed new treatments to patients as quickly as possible. We want to enable people, whether a partner, a parent, or a friend, to continue experiencing moments in life that mater. A cancer diagnosis should not be the end of these essential moments. That is why we work relentlessly to answer patients’ needs in the best possible way and continue on our journey to – one day – create a future where breast cancer is no longer a deadly disease.